Clinical review highlights treatment strategy uncertainty in low-risk aortic stenosis patients eligible for TAVI or SAVR, indicating a need for routine practice data.
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking on the appropriate treatment strategy in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Blankenberg et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: